Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...

Tools like Claimable and Fight Health Insurance use AI to guide people through the insurance appeals process and generate ...

Longer-term studies will be needed to track whether per-patient costs might drop over time with continued use of the meds.

Novo Nordisk surges as Wegovy secures FDA approval for MASH, marking a breakthrough in liver care and expanding its blockbuster reach.

GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, at a cash price of $499 per month.

Eli Lilly and Company’s LLY stock has declined 5.1% so far this month, despite announcing strong second-quarter results on ...

GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at ...